Ionis Pharma names Kyle Jenne new Chief Global Product Strategy Officer

Ionis Pharmaceuticals announced that Kyle Jenne has rejoined Ionis as EVP, Chief Global Product Strategy Officer, to lead all aspects of commercialization at the company. Jenne has more than 25 years of biopharmaceutical commercial and executive leadership experience. Onaiza Cadoret-Manier, Chief Global Product Strategy and Operations Officer, is leaving the company to pursue another opportunity. To support the transition, Cadoret-Manier will remain in a full-time capacity through March 15, after which she will serve as an advisor for a period of time. Jenne previously spent five years in commercial leadership roles at Ionis and Akcea, which was fully acquired by Ionis in 2020. His most recent role at Ionis was as EVP & chief commercial officer.